This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Molecular characterization of the novel rat NK receptor 1C7

Title Molecular characterization of the novel rat NK receptor 1C7
Abstract

A novel receptor, named 1C7 or NKp30 and involved in natural cytotoxicity, was recently identified. This receptor is encoded by the 1C7 gene, which is located within the class III region of the human MHC, HLA . It is a member of the immunoglobulin gene superfamily (IgSF) and, remarkably, is expressed at the mRNA level as six different splice variants in human. Recent investigations have indicated that the 1c7 gene of the mouse is silenced by in‐frame stop codons. In this study, the molecular characterization of the rat 1c7 gene is described. cDNA derived from this gene encode a protein of 192 amino acid residues predicted to contain a single IgV‐set domain in the extracellular region and a positively charged residue in the transmembrane region. Expression of the gene was detected in freshly isolated rat Natural Killer (NK) and T splenocytes. Transfection of rat 1C7 into the NK cell line RNK‐16 induced cytolytic activity against glioma as well as lymphoma tumor cells. In addition, binding of a r1C7‐Fc fusion protein by a panel of target cells correlated with susceptibility to killing by RNK‐16–1C7 effector cells. These results indicate that the r1C7 molecule could function as an NK activating receptor as previously reported for the human NKp30 receptor molecule.

Apa Reference Bäckman‐Petersson, E., Miller, J.R., Hollyoake, M., Aguado, B. & Butcher, G.W. (2003). Molecular characterization of the novel rat NK receptor 1C7. European Journal of Immunology, 33(2), 342-351. 10.1002/immu.200310008
Doi 10.1002/immu.200310008
Publication Date 20 Jan 2003
Publication Type Article
Researcher Begoña Aguado Orea †
Ontology
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home